Evaluation of the Pediatric Neuro-Oncology Resources Available in Chile
| Autor: | Nicolás Rojas del Río, Alvaro Lassaletta, Ibrahim Qaddoumi, Felipe Espinoza, José Santander, Katherine Kopp, Juan Tordecilla, Andres Morales La Madrid, Scott L. Coven, Ximena Espinoza, Eduardo Fernandez, Miguel Valero, Jonathan L. Finlay, Diana S Osorio, Verónica Pérez, Rosa Moreno, Ute Bartels, Veronica Oyarce, Adrián Cáceres, Mauricio Reyes, Mohammad H Abu-Arja |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Cancer Research
business.industry Hematopoietic Stem Cell Transplantation MEDLINE ORIGINAL REPORTS Medical Oncology medicine.disease Central Nervous System Neoplasms 03 medical and health sciences Cross-Sectional Studies 0302 clinical medicine Oncology Pediatric Oncology Pediatric Neuro-Oncology 030225 pediatrics 030220 oncology & carcinogenesis Material resources Humans Medicine Medical emergency Chile Child business |
| Zdroj: | JCO Global Oncology |
| ISSN: | 2687-8941 |
| DOI: | 10.1200/go.20.00430 |
| Popis: | PURPOSE Pediatric neuro-oncology resources are mostly unknown in Chile. We report the human and material resources available in Chilean hospitals providing pediatric neuro-oncology services. METHODS A cross-sectional survey was distributed to 17 hospitals providing pediatric neuro-oncology services (Programa Infantil Nacional de Drogas Antineoplásicas [PINDA] hospitals, 11; private, 6). RESULTS Response rate was 71% (PINDA, 8; private, 4). Pediatric neuro-oncology services were mainly provided within general hospitals (67%). Registries for pediatric CNS tumors and chemotherapy-related toxicities were available in 100% and 67% of hospitals, respectively. CNS tumors were treated by pediatric oncologists in 92% of hospitals; none were formally trained in neuro-oncology. The most used treatment protocols were the national PINDA protocols. All WHO essential medicines for childhood cancer were available in more than 80% of the hospitals except for gemcitabine, oxaliplatin, paclitaxel, and procarbazine. The median number of pediatric neurosurgeons per hospital was two (range, 2-6). General neuroradiologists were available in 83% of the centers. Pathology specimens were sent to neuropathologists (58%), adult pathologists (25%), and pediatric pathologists (17%). Intensity-modulated radiotherapy, conformal radiotherapy, and cobalt radiotherapy were used by 67%, 58%, and 42% of hospitals, respectively. Only one private hospital performed autologous hematopoietic cell transplant for children with CNS tumors. CONCLUSION A wide range of up-to-date treatment modalities are available for children with CNS tumors. Our survey highlights future directions to improve the pediatric neuro-oncology services available in Chile such as the expansion of multidisciplinary clinics, palliative care services, long-term cancer survivorship programs, dedicated clinical research support teams, establishing standardized mechanism for sending pathologic specimen for second opinion to international specialized centers, and establishing specialized neuro-oncology training program. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|